Modelling the effectiveness of ibrutinib versus rituximab-based chemotherapy regimens in relapsed/refractory mantle cell lymphoma

Authors:

Crtichlow S, Lee D, Latour A, Wildgust M, Goldberg J, Rule S and Wang M.

Publication Type:

Conference Proceedings – Poster

Publication Name:

19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Critchlow S, Lee D, Latour A, Wildgust M, Goldberg J, Rule S and Wang M. Modelling the effectiveness of ibrutinib versus rituximab-based chemotherapy regimens in relapsed/refractory mantle cell lymphoma. 19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Vienna Austria. 29 October – 2 November. Poster PCN138.

 


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies